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A biologically aclivc syn1hctic pcptidc. 2438. representing the 124-138 amino acid scquencc ol11lc human intcrfcron a-_ 7 (IFN a-2) n~olcculc, which 
is known IO possess IFN-like antiproliferative activity. specifically binds 10 human blood leukocytes. Scalchard plots rcvcal 1~0 ditTcrcn1 K,, V~IUCS, 
for the ‘low’ and ‘high’ arfiniiy binding. The inlcrac1ioo of the “51-labcllcd peplid, n 2438 with ~hecclls is no1 impnircd by human IFN a-2 or chokrd 
tosin. 
IFS a-2: Synlhctic pcp1ide; Specific binding: Human; Lymphocylc 
I. INTRODUCTION 
The family of IFN tl is a group of related proteins 
manifesting multiple biological activities [I]. Numerous 
structure-functional studies of IFN molecules revealed 
several areas associated with different biological activi- 
ties [Z--4]. Synthetic peptides representing fragments of 
IFN polypeptide chains are a good tool for identifica- 
tion of functionally important regions of these macro- 
molecules. 
A study of a synthetic peptide corresponding to the 
131-138 region of the human IFN a-2 moiecuie demon- 
strated its biological activity and specific binding to 
surface elements of mouse thymocytes. The binding of 
the labelled peptide 13!-I 38 to the cells was impaired 
by IFN a-2 and thymosin OL [5]. 
In an earlier work, we have slsown that a synthetic 
peptide, 2438. corresponding to tlie amino acid residues 
124-138 of the human IFN a-2 polypeptide chain, in- 
hibited proliferation of human blood leukocytes [6] but 
did not affect the activity of NK-cells (our unpublished 
data) and, in contrast to native IFN, this peptidc had 
no antiviral activity [7]. 
Ahhreei~trior~s: ConA, concanavalin A; IFN, in1erfcron; PBMC, pc- 
riphcral blood mononuclear cells; pcp1idc 2438, a syn1hclic pcpridc 
rcprcscnting \hc IFN a-2 amicc acid rcsihcs 1X-138. 
Cctrrrspotrclctrw r!r!!!rcss: A.V. Danilkovich, Dcparm~enl of Cellular 
Physiology and Immunology. Biological F;iculty, Moscow S1a1c Uni- 
vcrsily, Lenin’s Hill, Moscow 119899. USSR. 
In this study, we report on binding properties of the 
‘Wabelled synthetic peptide 2438. 
2. MATERIALS AND METHODS 
The pcp1ides corresponding to the amino acid residues 124-138 
(2338), 124-1~4 (2444). 129-138 (2938) and 129-144 (2944) OT 1hc 
human IFN a-2 molcculc wcrc synlhcsizcd as described [7]. 
2.1. lodittutiarr It/ pqttirle 2438 
50 jrg oi pcplide 2438 was iabcicd by solid phasc oxidalion usin& 
lodogcn (Sigma)and Na[‘z51] (0.5 rnCi: Amcrsham Corp.)asdcscribcd 
[8], and gel-iihra1cd on a column with Scphadcx G-IO (Pharmacia). 
The specific aclivity of the labcllcd pcp1idc was 2 x IO” cpm&g. 
PB,SK were ob1;:incd from blood of hcal1hy donors according lo 
Doyum [9]. Adherent cells wcrc rcmovcd by incubation on piaslic Peiri 
dishes l-or I II ~II 37°C in an almosphcrc of 5% CO:. A suspension or 
lymphocytes US divided into adhcren1 and non-adbcrcn1 subsets on 
a nylon wool column [IO]. A non-adhcrcn1 fKICliOfl WIS clutcd wilh 
RPM1 1640 medium supplemcn1cd wi1h 5% heat-imlctivatcd recta! x!f 
strum. This tixlion conlaincd T-lymphocy1cs and null cells with 
small amounts or monocytcs and B-lymphocytes. 
2.4. Clrlrrrra co11dirirttr,s 
PBMC (2 x IOh ccllslml) wcrc cultured in RPMI 1640 medium 
(Sigma) supplcmcn1cd with 5% hca1-inactiva1ed Te1al calf serum 
(Sigma), 100 mM L-glulamine, 50,@ml gentamicin. When ncccssary, 
concanavalin A (ConA) (2/@nl) or IFN a.2 (I000 IWml) wcrc added 
10 1hc cul1urc medium. Alicr culturing with Conit or IL2 I-or 20 h in 
a humid atmosphcrc or 5% CO: 81 37OC 1hc cells were harvencd, 
w;lshcd 1hrcc limes with fresh Incdium and used in binding ~SSZI~S. 
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Fig. I. Scalchard plol I’or the binding or 111~ ‘zsl-labcllcd pcplidc 2438 
IO normal PBhlC. 
PBMC or scparaicd T-lymphocytes (2 x lO”cclls!tubc) wcrc- incuba- 
[cd \vith the labcllcd pcplidc ‘$38 41 conccnlralions of IO-“-IO-” M 
for 40 min al -i’C in 100/A of 199 medium (S:rva) supplcmcnl-d with 
2% bovine swum albumin (Sigma). Aficr IIIC incubation, I~C cells wcrc 
wshcd by ccnwifualion ~lrrough 10% sucrose gradient as dcscribcd 
[I 11. and IIIC all-bound radioxtivity was measured in D Rack-Bela 
y.counwr (I_KB. Swdcn). In compchtiw binding assays PBMC wcrc 
i:!rub;ltcd with IO-” M or rhc labcllcd pcptidc 2438 in the prcs:nce 01 
IOO-fold mo!;ir CXCC’SS 01’ unlabcllcd IFN a-2. synthciic pcplidcs or 
cholera toxin (Calbiochcm). 
3. RESULTS AND DISCUSSlOX 
We analysed the binding of the labelled synthetic pep- 
tide 2438 to normal PBMC and T-lymphocytes, Fig. I 
presents a Scatcbard plot which is obviously curvilinear. 
As judged from the ScaLchard analysis of the binding to 
normal PBMC. there arc two distinct binding sites char- 
acuzrized by different dissociation const.ant values (K,,, 
= I.2 x IO-” M. and Kdz= I.2 x IO-‘” M, for ‘high’ and 
‘low’ affinity sites. respectively). 
The number of bigh- and low-affinity binding sites for 
PBMC is 2.01 x 10’ and I. 12 x IO’ per cell, respectively. 
As expected, the unlabclled pcptide 2438 effectively 
competes with the labellcd one for binding to PBMC. 
About 20-350/o f the peptide was estimated to bind 
nonspecifically (Fig. 2). Qualitatively and quantitatively 
similar results were obtained with separated T-lympho- 
cytes (data not shown). 
The results shown in Figs. I and 2 suggest that the 
peptide 2438 can specifically bind to human blood Icu- 
kocytes. 
According to Doolcy et al. [i?], Scatchard plots for 
the binding of IFN a-2 to normal PBMC arc also curvi- 
linear. Bearing in mind this analogy, we examined the 
ability of IFN a-2, cholera toxin and a number of IFN- 
derived pcptides of the 124-144 region to compete with 
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Fig. 2. Compclition bclwccn the “‘I-labclled and unlabcllcd pcptidc 
2438 for bindin& IO PBMC. Concentration of the “‘I-labcllcd pcptidc 
is IO-” M. 
the peptide 2438 for PBMC binding sites. All of these 
molecules are known to contain amino acid tracks of 
high local homology [ 131. The results of the competition 
experiments (Fig. 3) clearly demonstrate that neither the 
whole IFN a-2 molecule nor the aforementioned pep 
tides nor cholera toxin interfered with the binding of the 
labelled peptide 2438 to PMBC. 
The pretreatment of PBMC with ConA was found 
earlier to colnpletely block biological effects of both 
1FN a and the peptide 2438 (our unpublished data). On 
the other hand, the expression of the IFN-receptor is 
inhibited by pre-incubalion of cells with IFN [14411]1 
Therefore we characterized the effects of ConA and 
IFN on the peptide 2438 binding. To this end, prior lo 
binding measurements. PBMC were pre-incubated for 
20 h witb 2 pg/rnl ConA or 1000 lU/ml recombinant 
IFN a-2. In both cases, the binding of the peptide 2438 
was unaffected (data not shown). 
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Fig. 3. Efl’ccts or dil’fercnt competitors, added al R 100.fold molar 
excess. on binding or the ‘2V-labcllcd pcplidc 2438 IO PBMC. Compc- 
lilors: 2438.2444 and 2944 arc pcptidcs corresponding IO I~C 1X-138, 
IX-!44 and 129-144 amino acid scqucnccs 01’ lhc human IFN a-2 
molcculc; IFN, human intcrfcron a-2: CT, cholera toxin; C. control. 
wilhoul COmpclilOis. 
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These findings suggest hat (i) non-responsiveness of
ConA-activated PBMC to the peptide 2438 seems not 
to be associated with the lack of appropriate binding 
sites on the cell membrane. and (ii) prctrcatment of 
PBMC with IFN or ConA does not influence the bind- 
ing of the peptide to the cells. 
Although the present results may be interpreted as an 
indication that the peptide 2438 binds to membrane 
targets different from those for IFN 01-3. this conclusion 
needs additional support. The question of identity of 
ccl1 surface binding sites for IFN a-2 and the peptide 
2438 remains open and awaits further investigation. 
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